Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-25-000032

Options or other derivatives

  • Chief Product Strategy Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Chief Product Strategy Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-25 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X05/form4.xml…